Free Trial

enVVeno Medical (NVNO) Competitors

enVVeno Medical logo
$4.18 -0.14 (-3.24%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$4.33 +0.15 (+3.56%)
As of 07/11/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVNO vs. DRTS, NYXH, SMTI, ZIMV, SKIN, CATX, BWAY, TCMD, BSGM, and STIM

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Beauty Health (SKIN), Perspective Therapeutics (CATX), Brainsway (BWAY), Tactile Systems Technology (TCMD), Biosig Technologies (BSGM), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry.

enVVeno Medical vs. Its Competitors

Alpha Tau Medical (NASDAQ:DRTS) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Alpha Tau Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$31.75M-$0.46-6.65
enVVeno MedicalN/AN/A-$21.82M-$1.18-3.54

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 16.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. enVVeno Medical's average media sentiment score of 1.89 beat Alpha Tau Medical's score of 1.87 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Very Positive
enVVeno Medical Very Positive

Alpha Tau Medical currently has a consensus price target of $8.00, indicating a potential upside of 161.44%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Alpha Tau Medical is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Tau Medical has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500.

Alpha Tau Medical's return on equity of -49.48% beat enVVeno Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -49.48% -36.69%
enVVeno Medical N/A -51.32%-48.23%

Summary

Alpha Tau Medical beats enVVeno Medical on 8 of the 12 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVNO vs. The Competition

MetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$73.30M$6.73B$5.56B$9.10B
Dividend YieldN/A1.28%5.06%4.02%
P/E Ratio-3.5426.3028.2620.26
Price / SalesN/A85.55437.10165.28
Price / CashN/A20.3337.1257.67
Price / Book1.744.648.045.49
Net Income-$21.82M$174.76M$3.19B$250.45M
7 Day Performance2.20%-1.00%3.62%4.79%
1 Month Performance-3.69%0.99%5.98%9.59%
1 Year Performance-30.22%5.27%29.39%16.41%

enVVeno Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVNO
enVVeno Medical
0.6326 of 5 stars
$4.18
-3.2%
N/A-30.2%$73.30MN/A-3.5430Positive News
DRTS
Alpha Tau Medical
3.1796 of 5 stars
$3.23
-1.8%
$8.00
+147.7%
+37.8%$273.97MN/A-7.0280
NYXH
Nyxoah
2.5356 of 5 stars
$7.98
+1.5%
$14.50
+81.7%
-19.9%$271.80M$4.89M-3.75110
SMTI
Sanara MedTech
2.1819 of 5 stars
$30.30
+3.9%
$49.50
+63.4%
+0.6%$269.37M$86.67M-22.6160
ZIMV
ZimVie
2.0213 of 5 stars
$9.63
+2.1%
$16.33
+69.6%
-51.8%$268.20M$449.75M-13.561,770
SKIN
Beauty Health
0.2868 of 5 stars
$2.10
-4.5%
$1.42
-32.5%
-5.0%$264.58M$334.30M-5.121,030
CATX
Perspective Therapeutics
1.0491 of 5 stars
$3.53
+1.4%
$12.56
+255.7%
-69.2%$262.03MN/A0.0070
BWAY
Brainsway
2.6812 of 5 stars
$12.87
-3.7%
$14.25
+10.7%
+87.7%$243.24M$41.02M64.35120Gap Down
TCMD
Tactile Systems Technology
3.6492 of 5 stars
$9.98
+1.1%
$16.00
+60.3%
-17.1%$232.04M$292.98M15.121,037News Coverage
BSGM
Biosig Technologies
1.9533 of 5 stars
$8.39
-27.4%
$10.00
+19.2%
+1,145.2%$229.05M$40K0.0050Gap Up
High Trading Volume
STIM
Neuronetics
1.7144 of 5 stars
$3.42
+1.5%
$5.50
+60.8%
+90.9%$225.10M$74.89M-2.61180News Coverage

Related Companies and Tools


This page (NASDAQ:NVNO) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners